All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR GROUP REVENUES

EBITDA (2023)

90,4 (19,5% of turnover)

EBIT (2023)

66,4 (14,3% of turnover)

NET RESULT (2023)

45,2 (9,8%turnover)

Related Documents

Discover more

OUR GROUP FIGURES BY FOCUS AREA (%, 2023)

34,92 %

JOINT CARE

20,5 %

EYE CARE

13,69 %

SKIN CARE

13,67 %

PRIMARY CARE

6,76 %

SPECIALTY CARE

1,77 %

REGENERATIVE CARE

0,95 %

AESTHETIC CARE

7,74 %

OTHER

OUR FIGURES BY PRODUCT CATEGORY (2023)

43 %

MEDICAL DEVICES

40 %

PRESCRIPTION DRUGS

4 %

VACCINES

13 %

OTHER

OUR GROUP FIGURES BY GEOGRAPHICAL AREA (%, 2023)

51,7 %

ITALY

23,3 %

EUROPE

12 %

USA

4,8 %

MENA

8,2 %

RoW

OUR GROUP

GOVERNANCE

Find out more